Euroespes, S.A. functions as a healthcare institution, offering a range of medical services both domestically in Spain and internationally. Its primary mission involves the investigation, identification, and therapeutic management of central nervous system disorders, as well as various other ailments. The company specializes in personalized and genomic medicine, applied for predictive insights, accurate diagnosis, and effective treatment. Additionally, it provides specific medical disciplines such as neuro-ophthalmology, neuro-otorhinolaryngology, neuropsychology, advanced digital diagnostics, radiodiagnosis, comprehensive clinical laboratory analysis, nursing care, and cardiology services. Beyond its clinical offerings, Euroespes is dedicated to research and development across fields including biochemistry, health biotechnology, epigenetics, pharmacogenomics, and nutraceuticals. The entity was founded in 1991 and maintains its headquarters in Corunna, Spain.
The current price of EEP.MC is €0.34 EUR — it has increased by +0% in the past 24 hours. Watch Euroespes. stock price performance more closely on the chart.
What is Euroespes. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Madrid Exchange exchange Euroespes. stocks are traded under the ticker EEP.MC.
What is Euroespes. market cap?▼
Today Euroespes. has the market capitalization of 4.02M
What is Euroespes. revenue for the last year?▼
Euroespes. revenue for the last year amounts to 2.88M EUR.
What is Euroespes. net income for the last year?▼
EEP.MC net income for the last year is 1,000 EUR.
How many employees does Euroespes. have?▼
As of November 2, 2026, the company has 39 employees.
In which sector is Euroespes. located?▼
Euroespes. operates in the Health & Wellness sector.